本文關(guān)鍵詞：琥珀酸曲格列汀合成工藝及有關(guān)物質(zhì)研究　出處：《上海醫(yī)藥工業(yè)研究院》2017年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 琥珀酸曲格列汀 2型糖尿病 二肽基肽酶-4抑制劑 有關(guān)物質(zhì) 合成工藝

【摘要】：琥珀酸曲格列汀是第一個(gè)上市的口服長效二肽基肽酶-4抑制劑,用于2型糖尿病的治療,患者依從性高。Ⅲ期臨床研究證明,與每天一次口服阿格列汀相比,每周一次口服曲格列汀具有非劣效性,且安全性較好。本文以原研公司專利路線為基礎(chǔ)展開合成工藝研究,2-甲基-4-氟苯甲腈溴代生成溴芐5和二溴代物5’,其中5’再用亞磷酸二乙酯轉(zhuǎn)化成5,再與3-甲基-6-氯尿嘧啶反應(yīng)生成關(guān)鍵中間體6,6與(R)-3-氨基哌啶取代得到曲格列汀粗品。該粗品直接與琥珀酸成鹽,異丙醇/水重結(jié)晶后五步總收率61%(以2-甲基-4-氟苯甲腈計(jì)),純度大于99.9%,未檢出光學(xué)異構(gòu)體。在優(yōu)化6與(R)-3-氨基哌啶的取代反應(yīng)前,先合成了可能的有關(guān)物質(zhì)A~G,并建立了能有效分離各有關(guān)物質(zhì)及曲格列汀的HPLC方法,此方法為該反應(yīng)條件的篩選提供了指引。研究結(jié)果發(fā)現(xiàn):醇溶劑優(yōu)于非質(zhì)子性溶劑,空間位阻大的醇能避免雜質(zhì)生成,碳酸氫鈉作為堿優(yōu)于碳酸鉀和二異丙基乙胺。優(yōu)化后的取代反應(yīng)條件是以異丙醇為溶劑,碳酸氫鈉為堿,用該方法制得曲格列汀粗品純度94%以上,故可以省略專利報(bào)道的酸堿純化方法而與琥珀酸直接成鹽。由二溴代5’轉(zhuǎn)化成單溴代5的反應(yīng),亞磷酸二乙酯投料量降為文獻(xiàn)方法的1/4,二異丙基乙胺投料量降為1/5。整條路線中,專利共使用7種有機(jī)溶劑,包括1類溶劑1,2-二氯乙烷,而本研究割除1,2-二氯乙烷,僅用3種有機(jī)溶劑:二氯甲烷,四氫呋喃和異丙醇。本文共合成了A~J共10個(gè)曲格列汀的有關(guān)物質(zhì),其中有2個(gè)(D和G)未見文獻(xiàn)報(bào)道。10個(gè)化合物都經(jīng)1H-NMR和MS確證結(jié)構(gòu),并與藥物在HPLC能良好分離,為藥物的質(zhì)量研究提供基礎(chǔ)。
[Abstract]:Traglutin succinate is the first oral long-acting dipeptidyl peptidase-4 inhibitor to be used in the treatment of type 2 diabetes with high compliance. Oral traglutin once a week has a non-inferior effect and good safety. This paper is based on the patent route of the original research company to develop the synthesis process. 2-methyl-4-fluorobenzonitrile bromobenzyl 5 and dibromobenzyl 5 were formed. 5 '-diethyl phosphite was converted to 5 and then reacted with 3-methyl-6-chlorouracil to form the key intermediate 6. The crude product of triglutin was obtained by substitution with RPU-3- aminoperidol. The crude product was directly salted with succinic acid. The total yield of the crude product was 61% after recrystallization of isopropanol / water (based on 2-methyl-4-fluorobenzonitrile). The purity was greater than 99.9, and the optical isomer was not detected. Before the substitution reaction of 6 with RPG-3-aminoperidol was optimized, the possible related substance AfG was synthesized. A HPLC method for the effective separation of the related substances and trioglitine was established, which provided guidance for the screening of the reaction conditions. The results showed that the alcohol solvent was superior to the non-proton solvent. The alcohol with large steric hindrance can avoid the formation of impurity and sodium bicarbonate as base is superior to potassium carbonate and diisopropylethylamine. The optimized reaction conditions are as follows: isopropanol as solvent and sodium bicarbonate as base. The purity of the crude product of traglutin was over 94%, so the reaction of dibromo-5'to monobromo-5 'could be obtained by omitting the purification method of acid and base reported by patent and directly forming salt with succinic acid. The amount of diethyl phosphite was reduced to 1 / 4 of the method in the literature, and the amount of diisopropylethylamine was reduced to 1 / 5. In the whole route, seven organic solvents were used in the patent, including 1 / 2 dichloroethane, a kind of solvent. In this study, only three organic solvents, methylene dichloromethane, tetrahydrofuran and isopropanol, were used to separate 1 chloride-2-dichloroethane. Ten related substances of trioglentin were synthesized. The structures of 10 compounds were confirmed by 1H-NMR and MS, and they were well separated from the drug in HPLC, which provided the basis for the study of drug quality.
【學(xué)位授予單位】：上海醫(yī)藥工業(yè)研究院
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R914

【參考文獻(xiàn)】

相關(guān)期刊論文 前5條

1 褚青松;黃坤;李威;秦雄劍;;琥珀酸曲格列汀有關(guān)物質(zhì)的合成[J];中國藥物化學(xué)雜志;2016年04期

2 江潔瀅;游莉;鄧思思;鄧俊豐;劉瑜;張曉;;琥珀酸曲格列汀的合成[J];中國新藥雜志;2015年16期

3 廖涌;;中國糖尿病的流行病學(xué)現(xiàn)狀及展望[J];重慶醫(yī)科大學(xué)學(xué)報(bào);2015年07期

4 于凈平;陳武;朱雪焱;張喜全;常曉輝;劉相奎;;曲格列汀琥珀酸鹽的合成工藝[J];中國新藥雜志;2015年09期

5 趙哲;丁懷偉;趙明明;袁月;孟營;宋宏銳;;苯甲酸阿格列汀的合成工藝研究[J];中國醫(yī)藥導(dǎo)刊;2014年10期

，

本文編號：1420989